Acupuncture for emotional disorders in patients with inflammatory bowel disease: a systematic review protocol.
Acupuncture for emotional disorders in patients with inflammatory bowel disease: a systematic review protocol.
复制标题
针灸治疗炎症性肠病患者情绪障碍：系统评价方案
DOI：
10.1136/bmjopen-2021-058568
复制
发表时间：
2022-09-27
期刊：
影响因子：
2.9
通讯作者：
Liang, Fan-Rong
中科院分区：
文献类型：
--
作者：
Zhou, Yuan-Fang;Zhang, Gui-Long;Sun, Ning;Wang, Zhong-Quan;Ye, Xiang-Yin;Xiong, Jian;Deng, Xiao-Dong;Lin, Xin;Zhang, Pei;Zheng, Hao;Zhang, Yong;Yang, Kun;Gao, Ze-Da;Sun, Rui-Rui;Liang, Fan-Rong
关键词：
情绪障碍经常在炎症性肠病（IBD）中观察到。IBD伴情绪障碍导致生活质量差。本系统综述旨在评估针灸治疗IBD伴情绪障碍患者的有效性。检索科克伦对照试验中心数据库、MEDLINE、EMBASE、联合和补充医学数据库、护理与联合健康文献累积索引、中国国家知识基础设施、中国生物医学文献数据库、VIP数据库和万方数据库等9个电子数据库，检索时间为自成立至2021年10月，不受语言限制。还将检索包含会议记录的灰色文献，以及在明确出版物的参考文献中列出的系统综述。将纳入报告针灸治疗IBD伴情绪障碍的英文或中文随机对照试验。主要结果是情绪功能结果的变化。结肠炎活动指数、克罗恩病活动指数、C反应蛋白和不良事件将作为次要结局进行评估。两名以上的评估员将进行研究检索和选择，以及数据提取和偏倚风险评估。将使用基于异质性结果的随机效应模型进行数据合成。将使用RevMan软件（V.5.4）进行数据分析。此外，二分数据将以风险比表示，连续数据将使用加权平均差或标准平均差计算。本系统性综述不包含个体患者数据;因此，不需要伦理批准。此外，这一审查将在同行审查期刊或相关会议上传播。CRD 42020176340。
Emotional disorders are often observed in inflammatory bowel disease (IBD). IBD with emotional disorders leads to poor quality of life. This systematic review aims to assess the effectiveness of acupuncture in patients with IBD with emotional disorders. Nine electronic databases, including Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, Allied and Complementary Medicine Database, Cumulative Index to Nursing & Allied Health Literature, China National Knowledge Infrastructure, Chinese Biomedical Literature Database, VIP Database and Wanfang Database, will be searched from inception to October 2021 without language restriction. The grey literature containing conference proceedings, as well as systematic reviews listed in the reference of definite publications, will also be retrieved. Randomised controlled trials either in English or Chinese reporting acupuncture therapy for IBD with emotional disorders will be included. The primary outcome is changes of emotional functioning outcomes. The Colitis Activity Index, Crohn’s Disease Activity Index, C reactive protein and adverse events will be assessed as the secondary outcomes. More than two assessors will conduct the study retrieval and selection, as well as the data extraction and evaluation of the risk of bias. Data synthesis will be performed using a random-effects model based on the results of heterogeneity. Data analysis will be performed using RevMan software (V.5.4). Moreover, the dichotomous data will be presented as risk ratios, and the continuous data will be calculated using weighted mean difference or standard mean difference. This systematic review contains no individual patient data; thus, ethical approval is not required. Moreover, this review will be disseminated in a peer-reviewed journal or relevant conference. CRD42020176340.
登录
查看更多内容
影响因子：
2.7
作者：
Byrne G;Rosenfeld G;Leung Y;Qian H;Raudzus J;Nunez C;Bressler B
通讯作者：
Bressler B
影响因子：
--
作者：
Noguchi, Eitaro
通讯作者：
Noguchi, Eitaro
影响因子：
1.9
作者：
Joos, Stefanie;Wildau, Nicole;Brinkhaus, Benno
通讯作者：
Brinkhaus, Benno
影响因子：
3
作者：
Gol, Ali Sabbagh;Ardani, Amir Rezaei;Khorsand, Ali
通讯作者：
Khorsand, Ali
影响因子：
35.7
作者：
Alatab, Sudabeh;Sepanlou, Sadaf G.;Naghavi, Mohsen
通讯作者：
Naghavi, Mohsen